Literature DB >> 23340929

Micro-organisms isolated from cadaveric samples of allograft musculoskeletal tissue.

Kerry Varettas1.   

Abstract

Allograft musculoskeletal tissue is commonly used in orthopaedic surgical procedures. Cadaveric donors of musculoskeletal tissue supply multiple allografts such as tendons, ligaments and bone. The microbiology laboratory of the South Eastern Area Laboratory Services (SEALS, Australia) has cultured cadaveric allograft musculoskeletal tissue samples for bacterial and fungal isolates since 2006. This study will retrospectively review the micro-organisms isolated over a 6-year period, 2006-2011. Swab and tissue samples were received for bioburden testing and were inoculated onto agar and/or broth culture media. Growth was obtained from 25.1 % of cadaveric allograft musculoskeletal tissue samples received. The predominant organisms isolated were coagulase-negative staphylococci and coliforms, with the heaviest bioburden recovered from the hemipelvis. The rate of bacterial and fungal isolates from cadaveric allograft musculoskeletal tissue samples is higher than that from living donors. The type of organism isolated may influence the suitability of the allograft for transplant.

Entities:  

Mesh:

Year:  2013        PMID: 23340929     DOI: 10.1007/s10561-013-9363-3

Source DB:  PubMed          Journal:  Cell Tissue Bank        ISSN: 1389-9333            Impact factor:   1.522


  2 in total

1.  Postmortem angiography using femoral cannulation and postmortem microbiology.

Authors:  Cristian Palmiere; Coraline Egger; Silke Grabherr; Katia Jaton-Ogay; Gilbert Greub
Journal:  Int J Legal Med       Date:  2014-11-08       Impact factor: 2.686

2.  An allograft generated from adult stem cells and their secreted products efficiently fuses vertebrae in immunocompromised athymic rats and inhibits local immune responses.

Authors:  Bret H Clough; Eoin P McNeill; Daniel Palmer; Ulf Krause; Thomas J Bartosh; Christopher D Chaput; Carl A Gregory
Journal:  Spine J       Date:  2016-10-17       Impact factor: 4.166

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.